Paper42469812
Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation.
Lin Y and 9 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation. Papers, record 42469812. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42469812
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferrocyanides | Major topic |
| Cellular Senescence | Major topic |
| Macrophages | Major topic |
| Osteoporosis | Major topic |
| Animals | |
| Mice | |
| Reactive Oxygen Species | |
| Inflammation | |
| Tumor Necrosis Factor-alpha | |
| RANK Ligand | |
| RAW 264.7 Cells | |
| Humans | |
| Mice, Inbred C57BL | |
| Male |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82171581 | the National Natural Science Foundation of China | PubMed | ||
| S202410533139 | the National Undergraduate Innovation and Entrepreneurship Training Program | PubMed | ||
| X202510533658 | the Innovation Training Program for College Students, Central South University | PubMed | ||
| Y2024898 | the Hunan Provincial Basic Education Teaching Reform Research Project | PubMed | ||
| 2023jy100 | the Research Project on Education and Teaching Reform, Central South University | PubMed | ||
| 2022JJ40698 | the Hunan Provincial Natural Science Foundation | PubMed | ||
| S202510533421 | the Hunan Provincial College Students' Innovation and Entrepreneurship Training Program | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38387516 | Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/38387516 | PubMed |
| 2 | 34647005 | The spatial form periosteal-bone complex promotes bone regeneration by coordinating macrophage polarization and osteogenic-angiogenic events. | Mater Today Bio | 2021 | https://conductscience.org/library/papers/34647005 | PubMed |
| 3 | 26918394 | Prussian Blue Nanoparticles as Multienzyme Mimetics and Reactive Oxygen Species Scavengers. | J Am Chem Soc | 2016 | https://conductscience.org/library/papers/26918394 | PubMed |
| 4 | 38472175 | The HIF-1α/PLOD2 axis integrates extracellular matrix organization and cell metabolism leading to aberrant musculoskeletal repair. | Bone Res | 2024 | https://conductscience.org/library/papers/38472175 | PubMed |
| 5 | 37884477 | Engineered Macrophage Membrane-Coated Nanoparticles with Enhanced CCR2 Expression Promote Spinal Cord Injury Repair by Suppressing Neuroinflammation and Neuronal death. | Small | 2024 | https://conductscience.org/library/papers/37884477 | PubMed |
| 6 | 36978118 | MiR-21-5p regulates the dynamic of mitochondria network and rejuvenates the senile phenotype of bone marrow stromal cells (BMSCs) isolated from osteoporotic SAM/P6 mice. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/36978118 | PubMed |
| 7 | 27987311 | A novel isoform of the human mitochondrial complex I subunit NDUFV3. | FEBS Lett | 2017 | https://conductscience.org/library/papers/27987311 | PubMed |
| 8 | 39266768 | Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence. | Nat Aging | 2024 | https://conductscience.org/library/papers/39266768 | PubMed |
| 9 | 40075427 | Acid-responsive aggregated carrot-derived nanoantioxidants alleviate oxidative stress and restore osteoblast activity. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40075427 | PubMed |
| 10 | 30508677 | Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. | Pharmacol Res | 2019 | https://conductscience.org/library/papers/30508677 | PubMed |
| 11 | 38037521 | Macrophage-Biomimetic Nanoplatform-Based Therapy for Inflammation-Associated Diseases. | Small Methods | 2024 | https://conductscience.org/library/papers/38037521 | PubMed |
| 12 | 40034810 | Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40034810 | PubMed |
| 13 | 37777764 | Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review. | Cell Mol Biol Lett | 2023 | https://conductscience.org/library/papers/37777764 | PubMed |
| 14 | 31174843 | Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy. | Trends Cancer | 2019 | https://conductscience.org/library/papers/31174843 | PubMed |
| 15 | 40307557 | Cell cycle duration determines oncogenic transformation capacity. | Nature | 2025 | https://conductscience.org/library/papers/40307557 | PubMed |
| 16 | 40500258 | Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40500258 | PubMed |
| 17 | 28825716 | Targeting cellular senescence prevents age-related bone loss in mice. | Nat Med | 2017 | https://conductscience.org/library/papers/28825716 | PubMed |
| 18 | 34818042 | Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis. | Sci Adv | 2021 | https://conductscience.org/library/papers/34818042 | PubMed |
| 19 | 39721032 | SPP1-ITGα5/β1 Accelerates Calcification of Nucleus Pulposus Cells by Inhibiting Mitophagy via Ubiquitin-Dependent PINK1/PARKIN Pathway Blockade. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39721032 | PubMed |
| 20 | 35279261 | Drug therapy for osteoporosis in older adults. | Lancet | 2022 | https://conductscience.org/library/papers/35279261 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42469812
GET https://conductscience.org/api/papers/v1/42469812/references?page=2